Alpine Modifies Acazicolcept Deal with AbbVie, Ends Phase 2 Study Early (NASDAQ:ALPN)
mikhail_petrov-96 Alpine immune sciences (NASDAQ:ALPN) said it amended its 2020 option and license agreement with AbbVie (ABBV) for acazicolcept and ...
mikhail_petrov-96 Alpine immune sciences (NASDAQ:ALPN) said it amended its 2020 option and license agreement with AbbVie (ABBV) for acazicolcept and ...